Rovi Pharmaceuticals Laboratories
Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.
-
Could a shot every 3 months replace daily breast cancer pills?
Disease control Not yet recruitingThis study tests whether a new quarterly injection (Letrozole SIE) delivers the same amount of medication into the body as the standard daily letrozole pill. It involves 120 postmenopausal women who have already completed at least 4-5 years of hormone therapy for early breast can…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New shot could match pill for advanced breast cancer treatment
Disease control Not yet recruitingThis study tests if an injectable form of letrozole works as well as the standard pill (Femara) when both are combined with another drug (ribociclib) for postmenopausal women with a certain type of advanced breast cancer. About 300 women who have not had prior treatment for their…
Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated May 18, 2026 12:03 UTC